Cresset signs strategic alliance agreement to speed up drug design


A British-Chinese three-way agreement brings together expertise and innovation in the development of technologies for computational molecule design.

Add This Share Buttons

Cresset, innovative provider of software and contract research services for small molecule discovery and design, signs three-way strategic agreement to speed up drug design.

Dr David Bardsley, Commercial Director, Cresset visited the School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China to sign a strategic cooperation agreement for drug design technology, developed within the Research Centre for Drug Discovery (RCDD). This visit was in response to an invitation from Professor Jun Xu, RCDD, and was hosted by Mr Wenhao Hu, Dean of the School, and Huichang Bi, Vice Dean of the School for International Development.

A further agreement was signed between Dr Bardsley and Mr DeKang Zhang, Chairman, iPrecison Medicine Technology Inc., whereby Cresset will promote iPrecision software and technology globally. This agreement follows the transfer of 10 drug design software patents from RCDD to iPrecision last year.

“This British-Chinese three-way agreement brings together expertise and innovation in development of technologies for computational molecule design”, says Dr Bardsley, Cresset. “I look forward to working with each organization to establish global distribution channels.”


About Cresset

Cresset’s software and discovery research services are used by chemists from the world’s leading research organizations. Our patented methods deliver novel, realistic results for discovering, designing and optimizing the best small molecules in industry sectors including: agrochemicals, fine chemicals, flavor, fragrance and pharmaceuticals. For more information visit

About School of Pharmaceutical Sciences, Sun Yat-Sen University

School of Pharmaceutical Science (SPS), Sun Yat-sen University was established in June 2002, when the former Sun Yat-sen University and Sun Yat-sen Medical University were merged. SPS evolved from the Pharmacy Department of School of Live Sciences of Sun Yat-sen University. Relying on the comprehensive strength of the university, the school was founded by integrating the pharmaceutical research resource of School of Life Sciences, School of Chemistry and Chemical Engineering and Zhongshan School of Medicine. The establishment of SPS has obtained plenty supports from the university. President Daren Huang, the former president of Sun Yat-sen University urged to build a high level pharmacy school with solid foundation. Professor Xinzi Chen, the academician of Chinese Academy of Sciences, also the former Dean of SPS proposed an aim to develop the school into a first class pharmacy school of China in 5 to 10 years. With all these attention and supports , leadership of SPS have poured great efforts into discipline establishment, talents introduction, facilities improvement, regulation improvement, faculty motivation and culture nurture which advocates our people to be rigorous, practical, energetic, creative, agglomerate and harmonious. For more information visit



Sue Peffer, Marketing Manager,, +44 (0)1223 858890


To read more information, click here.

Computational solutions for drug discovery